EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Real-Time SYBR Green PCR Assay for Integron Profiling in Pseudomonas aeruginosa: Unveiling the Resistance Nexus Between Food and Clinical Isolates

Hend Emad, Mahmoud M Amer, Munirah M Alhammadi iD, Mona Alharbi, Yasmen F Mahran iD, Attia A Attia, Khalid Maniah, Azza SalahEldin El-Demerdash iD

Pathogens · 2026

DOI: 10.3390/pathogens15080788 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von Hend Emad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Botany and Microbiology, Faculty of Science, Benha University, Benha 13518, Egypt. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Integrons, Real-Time Polymerase Chain Reaction, Pseudomonas Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah bint Abdulrahman University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The dissemination of extensively drug-resistant Pseudomonas aeruginosa strains across the human–food interface represents a critical threat to global public health, complicating empirical therapeutic choices and challenging traditional nosocomial restriction paradigms.

Objective

This study investigated the prevalence, phenotypic resistome landscapes, and underlying integron-mediated mobilization mechanics of P. aeruginosa across the One Health continuum using an optimized real-time quantitative PCR (qPCR) platform.

Methods

A total of 116 samples comprising human clinical specimens (n = 61) and retail food matrices (n = 55) were screened. Phenotypic resistance was profiled against 16 antipseudomonal agents, with polymyxin and colistin resistance validated via reference broth microdilution. A novel real-time SYBR Green qPCR assay backed by derivative melting curve analysis was developed to track Class 1 (intI1) and Class 2 (intI2) integrons.

Results

Pseudomonas aeruginosa was recovered from 36.2% (n = 42/116) of total samples, exhibiting a homogeneous distribution across clinical (32.8%) and retail food matrices (40.0%, p = 0.445). Antibiogram characterization revealed a critical resistance burden: 100% of isolates fell into extreme epidemiological tiers, with 71.4% (n = 30) exhibiting an extensively drug-resistant (XDR) phenotype and 28.6% (n = 12) reaching absolute pandrug-resistant (PDR) status. Absolute phenotypic resistance (100%) was recorded across both cohorts for meropenem, ceftazidime, aztreonam, tobramycin, polymyxins, and novel combination therapeutics (ceftazidime–avibactam and ceftolozane–tazobactam). Pairwise tracking demonstrated an exceptionally strong positive correlation in resistance distribution patterns between human and food isolates (Spearman’s rho = 0.948, p < 0.001). Analytical validation of the qPCR assay demonstrated tight, reproducible specific derivative melting peaks (Tm) at 83.2 °C for intI1 and 83.8 °C for intI2. Genotypic screening revealed universal conservation of plasmid-borne intI1 (100%), whereas plasmidic intI2 was variably distributed (61.9%). Crucially, intI2 carriage served as a definitive marker for the transition to complete pandrug resistance, being detected in 100% (n = 12/12) of PDR isolates compared to 46.7% (n = 14/30) of XDR strains (p = 0.001), supported by a strong positive correlation with the PDR phenotype (rho = 0.496, p = 0.0008).

Conclusions

These findings reveal an overlapping, extreme resistome across the food-clinical interface and identify intI2 as a genetic tipping point for absolute pandrug resistance. The validated real-time assay provides a highly sensitive, proactive molecular surveillance framework capable of mapping high-risk mobile genetic platforms before they manifest as catastrophic empirical treatment failures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaIntegronsReal-Time Polymerase Chain ReactionPseudomonas InfectionsFood MicrobiologyDrug Resistance, Multiple, BacterialHumansAnti-Bacterial AgentsMicrobial Sensitivity TestsQuinolinesDiaminesOrganic ChemicalsBenzothiazoles

Stichwörter der Autor:innen

One HealthPseudomonasepidemiologypandrugplasmid-borne integronsresistome

Substanzen

Anti-Bacterial AgentsQuinolinesDiaminesSYBR Green IOrganic ChemicalsBenzothiazoles

Autor:innen und Institutionen

  • Department of Botany and Microbiology, Faculty of Science, Benha University, Benha 13518, Egypt.
  • Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.
  • Department of Biology, King Khalid Military Academy, P.O. Box 22140, Riyadh 11495, Saudi Arabia.
  • Department of Biotechnology, Agricultural Research Center (ARC), Animal Health Research Institute (AHRI), Zagazig 44516, Egypt.

ORCID-Profile: Munirah M Alhammadi, Yasmen F Mahran, Azza SalahEldin El-Demerdash

Förderung

  • Princess Nourah bint Abdulrahman University

Zitieren

APA

Emad, H., Amer, M. M., Alhammadi, M. M., Alharbi, M., Mahran, Y. F., Attia, A. A., Maniah, K., & El-Demerdash, A. S. (2026). A Novel Real-Time SYBR Green PCR Assay for Integron Profiling in Pseudomonas aeruginosa: Unveiling the Resistance Nexus Between Food and Clinical Isolates. Pathogens. https://doi.org/10.3390/pathogens15080788

Vancouver

Emad H, Amer MM, Alhammadi MM, Alharbi M, Mahran YF, Attia AA, et al. A Novel Real-Time SYBR Green PCR Assay for Integron Profiling in Pseudomonas aeruginosa: Unveiling the Resistance Nexus Between Food and Clinical Isolates. Pathogens. 2026. doi:10.3390/pathogens15080788

BibTeX
@article{Emad2026,
  author = {Emad, Hend and Amer, Mahmoud M and Alhammadi, Munirah M and Alharbi, Mona and Mahran, Yasmen F and Attia, Attia A and Maniah, Khalid and El-Demerdash, Azza SalahEldin},
  title = {A Novel Real-Time SYBR Green PCR Assay for Integron Profiling in Pseudomonas aeruginosa: Unveiling the Resistance Nexus Between Food and Clinical Isolates},
  journal = {Pathogens},
  year = {2026},
  doi = {10.3390/pathogens15080788}
}
Kostenlos starten →